Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and six months ended June 30, 2017. Read more >>
Now the Geoghegan family is hopeful that new technology will allow Max to finally see the big cats at Dreamworld, and everything else he has missed out on, but it is rare and expensive.
eSight glasses are available in the United States, Canada and Europe, but not in Australia. They contain a high-quality camera which projects the wearer’s view onto two small screens in front of the person’s eyes, through a live video feed. Read more >>
David Friend comes across as a modest, unassuming fellow who talks about his start-up storage company, Wasabi, and its technology in an understated, commonsensical kind of way. But make no mistake, Friend is pursuing a grand ambition that takes dead aim at a big target: the public cloud storage market, which Wasabi intends to turn on its head. Read more >>
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will release its unaudited financial results for the quarter ended June 30, 2017 on Monday, August 14, 2017, after the US markets close. Read more >>
ZetrOZ Systems LLC announced that its sam (sustained acoustic medicine) Sport medical device is being integrated into the U.S. Department of Veterans Affairs hospital system to help eliminate the need for using opioid-based pain medication. Read more >>
The city of Kirksville, Mo., will soon be using a new mass notification system to warn local residents about emergencies in the area.
The Kirksville City Council approved the purchase of a mass notification system from ReGroup during its meeting on Monday at City Hall. The agreement is a five-year deal and will cost the city $6,500 for the first year and $5,500 for the subsequent years. Read more >>
Wasabi secures more cash for data center expansion after cloud storage launch entices trial users on claims of significantly lower prices, higher performance than Amazon S3. Read more >>
Corbus Pharmaceuticals to Present New Data from Systemic Sclerosis Phase 2 Study of Anabasum at the 15th International Workshop on Scleroderma ResearchZiad
Corbus Pharmaceuticals Holdings, Inc.(NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that recently analyzed skin biopsy histology data from its Phase 2 study of anabasum for the treatment of diffuse cutaneous systemic sclerosis will be presented at the 15th International Workshop on Scleroderma Research. Read more >>
A legally blind man who had not been able to see a soccer match in almost 30 years recently watched his favorite club live with the help of eSight’s visual aid technology. Read more >>
For the first time in 25 years of teaching at Cardinal O’Hara, Ed Allen can see what the hall ways really look like.
“It’s awesome just being able to see this building,” Allen said.
His awesome new world is thanks to the funny looking glasses called eSight. Read more >>